Exact Sciences‘ Oncodetect molecular residual disease (MRD) test has received Medicare coverage through the Centers for Medicare & Medicaid Services (CMS) Molecular Diagnostic Services Program (MolDX), the company announced recently….
SHINE Technologies has entered into a strategic partnership with Standard Nuclear, a reactor-agnostic producer of TRISO nuclear fuel and radioisotope power systems, SHINE announced today. According to a release, the…
Voximetry and Medpace Core Laboratories, a full-service core laboratory, have entered a strategic partnership aimed at enhancing radiopharmaceutical clinical trials through the integration of cutting-edge dosimetry technology and comprehensive contract…
Cellectar Biosciences and Nusano, a physics company transforming the production of radioisotopes, signed a multi-year supply agreement, the company announced recently. According to a release, Nusano will provide Cellectar with…
Archeus Technologies has received FDA clearance for its Investigational New Drug (IND) application for ART-101, a novel receptor-based targeting small molecule developed for the imaging and treatment of prostate cancer,…
Voximetry and Y-mAbs, a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radiopharmaceuticals and commercial-stage antibody-based therapeutic products for the treatment of cancer, have entered into a…
Axio BioPharma and Likarda, a company focused on advanced drug delivery and formulation technologies, announced today a strategic partnership to accelerate innovation in biologic drug development. According to a release,…
Archeus Technologies, a company developing multiple differentiated radiopharmaceutical therapies, and the Wisconsin Alumni Research Foundation (WARF) have entered into a strategic collaboration to advance ART-101, a receptor-based targeting molecule, into…
Forward BIOLABS is expanding to Milwaukee to further strengthen Wisconsin’s biohealth ecosystem for young companies, the organization announced recently. According to a release, these efforts also include expanding Forward BIOLABS’ facility…
Invenra has launched its T-Body™ trispecific antibody platform, a next-generation technology designed to direct correct chain pairing and afford high expression and assembly efficiency in a variety of antibody constructs,…
